VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...
The U.S. Lipid Nanoparticle CDMO Market is projected to reach USD 0.44 billion by 2035, while Europe is expected to reach USD 0.27 billion, driven by expanding mRNA, siRNA, gene-editing therapeutics, ...
Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic ...
VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO) ("Onco" or the "Company") is pleased to announce that it has entered into a services agreement with Nanosoft ...
In this webinar, learn how advanced nanoparticle characterization improves formulation stability, product quality, and ...
Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturing ...
Clinical Program Advances Following Favorable Safety Review; Peer-Reviewed Publication Further Validates Deciparticle™ Platform ...
Detailed price information for Rzolv Technologies Inc (RZL-X) from The Globe and Mail including charting and trades.
New research could help make future mRNA vaccines easier to store and distribute. The study, involving RMIT University, the ...
Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for ...
Mood and anxiety disorders represent a leading cause of disability worldwide. Current first-line pharmacological treatments, ...
New research could help make future mRNA vaccines easier to store and distribute. The study, involving RMIT University, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results